After treatment with CAR-T cells - immune cells engineered to attack cancer - patients sometimes tell their doctors they feel like they have "brain fog," or forgetfulness and difficulty concentrating.

A rapidly developed, dual-target chimeric antigen receptor T-cell therapy produced a 100% overall response rate in patients ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including ...

KINGSTON — A groundbreaking innovation in cancer therapy is now available in the Limestone City thanks to the work and ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including ...

A next-generation, anti-CD19 enhanced (or "armored") CAR T-cell product showed promising efficacy and safety in a phase I ...

AIC100 is a third generation CAR T cell therapy that works by binding to ICAM-1 on tumor ... Based on efficacy and safety ...

Still, if a battery-electric Miata were to happen, this patent sure is a promising way to lay it all out, as the battery ...